Abivax Operating Expenses Growth & History (ABVX)
Abivax's operating expenses was €250.6M for fiscal 2025.
View full Abivax company overviewAbivax annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €250.6M | €65.2M | +35.16% |
| 2024 | 2024-12-31 | €185.4M | €53.4M | +40.48% |
| 2023 | 2023-12-31 | €132.0M | €62.6M | +90.15% |
| 2022 | 2022-12-31 | €69.4M | €16.1M | +30.09% |
| 2021 | 2021-12-31 | €53.4M | — | — |
Abivax quarterly operating expenses
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q1 2026 | 2026-03-31 | €56.2M | €8.0M | +16.67% |
| Q4 2025 | 2025-12-31 | €72.1M | €25.0M | +53.03% |
| Q3 2025 | 2025-09-30 | €82.8M | €31.2M | +60.65% |
| Q2 2025 | 2025-06-30 | €47.6M | €6.6M | +16.20% |
| Q1 2025 | 2025-03-31 | €48.2M | €2.3M | +5.10% |
| Q4 2024 | 2024-12-31 | €47.1M | — | — |
| Q3 2024 | 2024-09-30 | €51.5M | — | — |
| Q2 2024 | 2024-06-30 | €41.0M | — | — |
| Q1 2024 | 2024-03-31 | €45.9M | — | — |
Abivax operating expenses trends
Between the periods ended 2021-12-31 and 2025-12-31, Abivax's operating expenses increased from €53.4M to €250.6M, a change of €197.3M. The latest reported quarter, Q1 2026, shows €56.2M.
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Abivax source filings ↗